Intracellular aggregation of multimodal silica nanoparticles for ultrasound-guided stem cell implantation

Science Translational Medicine

Volumn 5, Issue 177, 2013, Pages

  Jokerst, Jesse V ^a   Khademi, Christine ^a   Gambhir, Sanjiv S ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NANOPARTICLE; SILICON DIOXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL AGGREGATION; CELL LABELING; CELL METABOLISM; CELL PROLIFERATION; CONTROLLED STUDY; ECHOGRAPHY; ELECTRON MICROSCOPY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HEART LEFT VENTRICLE WALL; HEART MUSCLE CELL; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARACRINE SIGNALING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REAL TIME ECHOGRAPHY; STEM CELL TRANSPLANTATION; TISSUE REPAIR;

CELL TRACKING; CELLS, CULTURED; HUMANS; MAGNETIC RESONANCE IMAGING; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; NANOPARTICLES; SILICON DIOXIDE;

EID: 84876011934     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3005228     Document Type: Article

References (37)

1. G. P. Meyer, K. C. Wollert, J. Lotz, J. Steffens, P. Lippolt, S. Fichtner, H. Hecker, A. Schaefer, L. Arseniev, B. Hertenstein, A. Ganser, H. Drexler, Intracoronary bone marrow cell transfer after myocardial infarction: Eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation 113, 1287-1294 (2006).
2. R. H. Lee, A. A. Pulin, M. J. Seo, D. J. Kota, J. Ylostalo, B. L. Larson, L. Semprun-Prieto, P. Delafontaine, D. J. Prockop, Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 5, 54-63 (2009).
3. R. Bolli, A. R. Chugh, D. D'Amario, J. H. Loughran, M. F. Stoddard, S. Ikram, G. M. Beache, S. G. Wagner, A. Leri, T. Hosoda, F. Sanada, J. B. Elmore, P. Goichberg, D. Cappetta, N. K. Solankhi, I. Fahsah, D. G. Rokosh, M. S. Slaughter, J. Kajstura, P. Anversa, Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): Initial results of a randomised phase 1 trial. Lancet 378, 1847-1857 (2011).
4. A. R. Williams, J. M. Hare, Mesenchymal stem cells: Biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ. Res. 109, 923-940 (2011).
5. S. H. Ranganath, O. Levy, M. S. Inamdar, J. M. Karp, Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell 10, 244-258 (2012).
6. B. Parekkadan, J. M. Milwid, Mesenchymal stem cells as therapeutics. Annu. Rev. Biomed. Eng. 12, 87-117 (2010).
7. M. Gnecchi, Z. Zhang, A. Ni, V. J. Dzau, Paracrine mechanisms in adult stem cell signaling and therapy. Circ. Res. 103, 1204-1219 (2008).
8. I. J. de Vries,W. J. Lesterhuis, J. O. Barentsz, P. Verdijk, J.H. van Krieken, O. C. Boerman, W. J. Oyen, J. J. Bonenkamp, J. B. Boezeman, G. J. Adema, J. W. Bulte, T. W. Scheenen, C. J. Punt, A. Heerschap, C. G. Figdor, Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat. Biotechnol. 23, 1407-1413 (2005).
9. J. W. M. Bulte, In vivo MRI cell tracking: Clinical studies. AJR Am. J. Roentgenol. 193, 314-325 (2009).
10. M. Rodriguez-Porcel, O. Gheysens, I. Y. Chen, J. C. Wu, S. S. Gambhir, Image-guided cardiac cell delivery using high-resolution small-animal ultrasound. Mol. Ther. 12, 1142-1147 (2005).
11. J. V. Frangioni, R. J. Hajjar, In vivo tracking of stem cells for clinical trials in cardiovascular disease. Circulation 110, 3378-3383 (2004).
12. M. A. Pysz, J. K. Willmann, Targeted contrast-enhanced ultrasound: An emerging technology in abdominal and pelvic imaging. Gastroenterology 140, 785-790 (2011).
13. S. Casciaro, F. Conversano, A. Ragusa, M. A. Malvindi, R. Franchini, A. Greco, T. Pellegrino, G. Gigli, Optimal enhancement configuration of silica nanoparticles for ultrasound imaging and automatic detection at conventional diagnostic frequencies. Invest. Radiol. 45, 715-724 (2010).
14. H. P. Martinez, Y. Kono, S. L. Blair, S. Sandoval, J. Wang-Rodriguez, R. F. Mattrey, A. C. Kummel, W. C. Trogler, Hard shell gas-filled contrast enhancement particles for colour Doppler ultrasound imaging of tumors. Med. Chem. Commun. 1, 266-270 (2010).
15. J. K. Hsiao, C. P. Tsai, T. H. Chung, Y. Hung, M. Yao, H. M. Liu, C. Y. Mou, C. S. Yang, Y. C. Chen, D. M. Huang, Mesoporous silica nanoparticles as a delivery system of gadolinium for effective human stem cell tracking. Small 4, 1445-1452 (2008).
16. Memorial Sloan-Kettering Cancer Center, ClinicalTrials.gov identifier NCT01266096.
17. J. Liu, A. L. Levine, J. S. Mattoon, M. Yamaguchi, R. J. Lee, X. Pan, T. J. Rosol, Nanoparticles as image enhancing agents for ultrasonography. Phys. Med. Biol. 51, 2179-2189 (2006).
18. L. M. Rossi, L. Shi, F. H. Quina, Z. Rosenzweig, Stöber synthesis of monodispersed luminescent silica nanoparticles for bioanalytical assays. Langmuir 21, 4277-4280 (2005).
19. M. Amaral, M. Costa, M. Lopes, R. Silva, J. Santos, M. Fernandes, Si3N4-bioglass composites stimulate the proliferation of MG63 osteoblast-like cells and support the osteogenic differentiation of human bone marrow cells. Biomaterials 23, 4897-4906 (2002).
20. S. E. Boddington, E. J. Sutton, T. D. Henning, A. J. Nedopil, B. Sennino, A. Kim, H. E. Daldrup-Link, Labeling human mesenchymal stem cells with fluorescent contrast agents: The biological impact. Mol. Imaging Biol. 13, 3-9 (2011).
21. S. Makino, K. Fukuda, S. Miyoshi, F. Konishi, H. Kodama, J. Pan, M. Sano, T. Takahashi, S. Hori, H. Abe, J. Hata, A. Umezawa, S. Ogawa, Cardiomyocytes can be generated from marrow stromal cells in vitro. J. Clin. Invest. 103, 697-705 (1999).
22. M. J. Derelanko, M. A. Hollinger, Handbook of Toxicology (Informa HealthCare, 2001).
23. S. T. Wolford, R. A. Schroer, F. X. Gohs, P. P. Gallo, M. Brodeck, H. B. Falk, R. Ruhren, Reference range data base for serum chemistry and hematology values in laboratory animals. J. Toxicol. Environ. Health 18, 161-188 (1986).
24. T. H. Chung, S. H. Wu, M. Yao, C. W. Lu, Y. S. Lin, Y. Hung, C. Y.Mou, Y. C. Chen, D. M. Huang, The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells. Biomaterials 28, 2959-2966 (2007).
25. F. S. Foster, M. Y. Zhang, Y. Q. Zhou, G. Liu, J. Mehi, E. Cherin, K. A. Harasiewicz, B. G. Starkoski, L. Zan, D. A. Knapik, S. L. Adamson, A new ultrasound instrument for in vivo microimaging of mice. Ultrasound Med. Biol. 28, 1165-1172 (2002).
26. J. Ankrum, J. M. Karp, Mesenchymal stem cell therapy: Two steps forward, one step back. Trends Mol. Med. 16, 203-209 (2010).
27. D. R. Arifin, C. M. Long, A. A. Gilad, C. Alric, S. Roux, O. Tillement, T. W. Link, A. Arepally, J. W. Bulte, Trimodal gadolinium-gold microcapsules containing pancreatic islet cells restore normoglycemia in diabetic mice and can be tracked by using US, CT, and positivecontrast MR imaging. Radiology 260, 790-798 (2011).
28. B. P. Barnett, J. Ruiz-Cabello, P. Hota, R. Ouwerkerk, M. J. Shamblott, C. Lauzon, P. Walczak, W. D. Gilson, V. P. Chacko, D. L. Kraitchman, A. Arepally, J. W. Bulte, Use of perfluorocarbon nanoparticles for non-invasive multimodal cell tracking of human pancreatic islets. Contrast Media Mol. Imaging 6, 251-259 (2011).
29. S. Y. Nam, L. M. Ricles, L. J. Suggs, S. Y. Emelianov, In vivo ultrasound and photoacoustic monitoring ofmesenchymal stemcells labeledwith gold nanotracers. PLoSOne 7, e37267 (2012).
30. J. V. Jokerst, M. Thangaraj, P. J. Kempen, R. Sinclair, S. S. Gambhir, Photoacoustic imaging of mesenchymal stem cells in living mice via silica-coated gold nanorods. ACS Nano 6, 5920-5930 (2012).
31. N. Deshpande, A. Needles, J. K. Willmann, Molecular ultrasound imaging: Current status and future directions. Clin. Radiol. 65, 567-581 (2010).
32. T. Grobner, Gadolinium - A specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol.Dial. Transplant. 21, 1104-1108 (2006).
33. J. G. Penfield, R. F. Reilly, What nephrologists need to know about gadolinium. Nat. Clin. Pract. Nephrol. 3, 654-668 (2007).
34. Z. Li, Y. Suzuki, M. Huang, F. Cao, X. Xie, A. J. Connolly, P. C. Yang, J. C. Wu, Comparison of reporter gene and iron particle labeling for tracking fate of human embryonic stem cells and differentiated endothelial cells in living subjects. Stem Cells 26, 864-873 (2008).
35. J. M. Hare, J. H. Traverse, T. D. Henry, N. Dib, R. K. Strumpf, S. P. Schulman, G. Gerstenblith, A. N. DeMaria, A. E. Denktas, R. S. Gammon, J. B. Hermiller Jr., M. A. Reisman, G. L. Schaer, W. Sherman, A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J. Am. Coll. Cardiol. 54, 2277-2286 (2009).
36. S. A. Dunbar, Applications of Luminex xMAP technology for rapid, high-throughput multiplexed nucleic acid detection. Clin. Chim. Acta 363, 71-82 (2006).
37. M. D. Abramoff, P. J. Magalhaes, S. J. Ram, Image processing with ImageJ. Biophotonics Int. 11, 36-42 (2004).